Lupin to focus on developing inhalers with near-zero global warming potential propellants

Lupin Limited announced their focus on formulating respiratory inhalers with near-zero global warming potential. This initiative aims to provide patients with effective and safe pressurized metered dose inhalers while reducing their environmental impact. The company’s strategy includes the accelerated development of pipeline products and green propellant programs.